When Harm Reduction Isn’t Reducing Harm | Episode 092 with Michael Brown

In this episode of the Drug Prevention Power Hour, host Jake White speaks with Michael Brown, a retired DEA agent and current director of counter-narcotics technology at Rigaku Analytical Devices. They discuss Michael's extensive background in drug enforcement, the role of technology in combating drug trafficking, and the importance of community coalitions in addressing the opioid crisis. Michael shares insights on the challenges posed by progressive harm reduction policies and emphasizes the need for a cultural shift in how society views drug use and prevention. The conversation highlights the urgency of implementing effective strategies to combat the growing drug epidemic in America.Chapters00:00 Introduction to Michael Brown's Background03:50 The Role of Technology in Counter-Narcotics06:38 Global Drug Trafficking and Coalition Building09:47 Challenges of Progressive Harm Reduction Policies12:55 The Thin Line of Enabling vs. Supporting15:44 Cultural Perspectives on Drug Use and Prevention18:53 The Importance of Community and Values21:43 The Need for Radical Change in Drug Policy24:55 Conclusion and Call to Action31:53 Introduction to Drug Prevention Strategies31:55 Engaging Youth in Substance Use EducationLinks from Michael BrownLinkedIn https://www.linkedin.com/in/michaelwbrownusa/ The Opioid Matrix podcast https://open.spotify.com/show/3Arn07SMtGFyGbE3Tj1JxV TakeawaysMichael Brown has over 33 years of experience in drug enforcement.Raman technology can significantly aid in identifying drug precursors.A global coalition is essential to combat drug trafficking effectively.Progressive harm reduction policies can lead to increased drug use.Community involvement is crucial in drug prevention efforts.Cultural values play a significant role in substance abuse rates.Faith and community support can help prevent drug addiction.Effective drug prevention requires a multi-faceted approach.The drug crisis is at a critical stage that requires urgent action.Education and collaboration are key to overcoming drug challenges.For feedback, questions and new episode [email protected]/vive18_